双重作用化合物释放出对结核病的双重打击
Wendy Le Mouëllic1, Yannick Poquet1, Olivier Neyrolles1
1Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France.
Cell chemical biology
|April 19, 2024
概括
研究人员发现了针对结核病的新型化合物,通过抑制毒性和提高药物的有效性来抑制结核病. 这种双重行动的方法为开发新的多点结核病治疗方法提供了一个有希望的战略.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 化学生物学 化学生物学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,需要新的治疗策略.
- 现有的治疗方法面临诸如耐药性和长时间治疗方案等挑战.
- 向毒性因素,如ESX-1分泌系统,提供了一种替代方法来对抗结核病.
研究的目的:
- 为了识别具有抗结核活性的新型化合物.
- 发现具有双重作用模式的化合物:抑制ESX-1毒性系统并增强现有药物的疗效,如ethionamide.
主要方法:
- 使用一种创新的选方法来识别潜在的候选药物.
- 查的重点是那些可以同时向毒性和增强埃西奥纳米德活性的化合物.
主要成果:
- 这项研究成功地确定了对Mycobacterium tuberculosis表现出双重作用模式的化合物.
- 这些化合物对第七类分泌系统ESX-1表现出抗病毒效应.
- 鉴定到的化合物还显示,当与ethionamide结合使用时,其疗效提高.
结论:
- 这些已识别的化合物代表了一种有前途的新型抗结核剂.
- 这种双重行动战略有可能开发多向药物来克服结核病耐药性.
- 这些发现可能为结核病治疗中的新型临床应用铺平道路.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.8K
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.5K
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis II
228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
